Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilofer S Azad

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Oncotarget|April 18, 2013
DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cellsM Zulfiquer Hossain, Megan A Healey, Calvin Lee, et al.
Cancer Journal (Sudbury, Mass.)|December 17, 2009
Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United StatesDiane K Reyes, Josephina A Vossen, Ihab R Kamel, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2016
A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancerMuhammad S Beg, Nilofer S Azad, Sandip P Patel, et al.
The Oncologist|August 16, 2022
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017Milind Javle, Sunyoung Lee, Nilofer S Azad, et al.
Radiation Oncology (London, England)|August 21, 2019
Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinomaAngela Y Jia, Amol Narang, Bashar Safar, et al.
NPJ Precision Oncology|November 19, 2025
Profiling ADC targets in cholangiocarcinoma: implications for therapeutic developmentMari Nakazawa, Waqar Arif, Ezra Baraban, et al.
Cancer|October 10, 2013
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastasesGeorgios Karagkounis, Michael S Torbenson, Hubert D Daniel, et al.
JCI Insight|May 8, 2020
Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancerVictoria M Kim, Xingyi Pan, Kevin C Soares, et al.
Clinical Epigenetics|April 29, 2023
A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancerMarina Baretti, Adrian G Murphy, Marianna Zahurak, et al.
British Journal of Cancer|January 10, 2018
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinomaRachna T Shroff, Mark Yarchoan, Ashley O'Connor, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Oncotarget|April 18, 2013
DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cellsM Zulfiquer Hossain, Megan A Healey, Calvin Lee, et al.
Cancer Journal (Sudbury, Mass.)|December 17, 2009
Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United StatesDiane K Reyes, Josephina A Vossen, Ihab R Kamel, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2016
A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancerMuhammad S Beg, Nilofer S Azad, Sandip P Patel, et al.
The Oncologist|August 16, 2022
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017Milind Javle, Sunyoung Lee, Nilofer S Azad, et al.
Radiation Oncology (London, England)|August 21, 2019
Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinomaAngela Y Jia, Amol Narang, Bashar Safar, et al.
NPJ Precision Oncology|November 19, 2025
Profiling ADC targets in cholangiocarcinoma: implications for therapeutic developmentMari Nakazawa, Waqar Arif, Ezra Baraban, et al.
Cancer|October 10, 2013
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastasesGeorgios Karagkounis, Michael S Torbenson, Hubert D Daniel, et al.
JCI Insight|May 8, 2020
Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancerVictoria M Kim, Xingyi Pan, Kevin C Soares, et al.
Clinical Epigenetics|April 29, 2023
A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancerMarina Baretti, Adrian G Murphy, Marianna Zahurak, et al.
British Journal of Cancer|January 10, 2018
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinomaRachna T Shroff, Mark Yarchoan, Ashley O'Connor, et al.
Pageof 11